ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "population studies"

  • Abstract Number: 0239 • ACR Convergence 2023

    Incidence and Prevalence of Cardiovascular and Metabolic Diseases Following Gout Diagnosis in the United Kingdom Using the THIN Database

    Michael Garshick1, Haridarshan Patel2, ada Kumar2, Brian LaMoreaux2, Lissa Padnick-Silver2, Louis Dron3, Vinusha Kalatharan3, Vivek Verma3 and Michael Pillinger4, 1NYU School of Medicine/NYU Langone Medical Center, New York, NY, 2Horizon Therapeutics, Deerfield, IL, 3Cytel Canada Inc., Vancouver, BC, Canada, 4New York University Grossman School of Medicine, New York, NY

    Background/Purpose: Gout is a common inflammatory arthropathy characterized by pain, joint swelling, and monosodium urate crystal deposits in joints, organs, and soft tissues.1 While gout…
  • Abstract Number: 0251 • ACR Convergence 2023

    Sodium-glucose Cotransporter-2 Inhibitor Initiation, Risk of Recurrent Gout Flares, and Mortality in Patients with Gout and Type 2 Diabetes: A Population-based Cohort Study

    Jie Wei1, Hyon K. Choi2, Nicola Dalbeth3, Xiaoxiao Li4, Changjun Li5, Chao Zeng6, Guanghua Lei6 and Yuqing Zhang7, 1Health Management Center, Xiangya Hospital Central South University, Changsha, China, 2Massachusetts General Hospital and Harvard Medical School, Lexington, MA, 3University of Auckland, Auckland, New Zealand, 4Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China, 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China, 6Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China, 7Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA

    Background/Purpose: Recurrent flares are the hallmark of clinical manifestation of gout. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were associated with a lower risk of incident gout; however,…
  • Abstract Number: 0475 • ACR Convergence 2023

    Prevalence of Endometriosis and Polycystic Ovarian Syndrome in Patients with Rheumatic Diseases in the United States

    Sabahat Usmani1, Catherine Lavallee2, Maria Antonelli3 and Cuoghi Edens4, 1Weiss Memorial Hospital, Chicago, IL, 2Virginia Tech Carilion School of Medicine, Roanoke, VA, 3MetroHealth System, Cleveland, OH, 4University of Chicago, Chicago, IL

    Background/Purpose: Endometriosis (ENDO) and Polycystic Ovarian Syndrome (PCOS) are underdiagnosed, often debilitating conditions with unknown etiologies that, like rheumatic diseases, affect reproductive-aged women. Recent studies…
  • Abstract Number: 0543 • ACR Convergence 2023

    Sensitivity of the 2019 European Alliance of Associations for Rheumatology /American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-based Cohort; A Study Set in Norway 2000-2015

    Hilde Haukeland1, Sigrid Reppe Moe1, Cathrine Brunborg2, Antonela Botea3, Nenad Damjanic4, Gro Wivestad5, Heidi Øvreås6, Thea Bøe7, Torhild Garen1, Anniken Orre8, Helga Sanner9, Øyvind Molberg10 and Karoline Lerang9, 1Oslo University Hospital, Department of Rheumatology, Oslo, Norway, 2Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital - Rikshospitalet, Oslo, Norway, 3Betanien Hospital, Department of Rheumatology, Skien, Norway, 4Ostfold Hospital Trust, Department of Rheumatology,, Grålum, Norway, 5Hospital of Southern Norway Trust, Division of Rheumatology, Department of Medicine, Kristiansand, Norway, 6Lillehammer Hospital for Rheumatic Diseases, Department of Rheumatology, Lillehammer, Norway, 7Vestfold Hospital Trust, Department of Internal Medicine, Tønsberg, Norway, 8Vestre Viken Hospital Trust, Department of Rheumatology, Drammen, Norway, 9Oslo University Hospital, Department of Rheumatology, Nydalen, Norway, 10University of Oslo, Institute of Clinical Medicine, Oslo, Norway

    Background/Purpose: To diagnose Systemic Lupus Erythematosus (SLE), one must understand the phenotype specter and interpret clinical, serological, radiological, and histopathological data, as well as exclude…
  • Abstract Number: 0751 • ACR Convergence 2023

    Recombinant Zoster Vaccination Among U.S. Veterans Receiving Immunosuppressive Medications 2017-2023

    Sharon Abada1, Jing Li1, Gary Tarasovsky2, Cherish Wilson3, Jinoos Yazdany1, Mary Whooley1 and Gabriela Schmajuk3, 1University of California San Francisco, San Francisco, CA, 2San Francisco VA, San Francisco, CA, 3UCSF / SFVA, San Francisco, CA

    Background/Purpose: Patients receiving immunosuppressive therapies are known to have a higher risk of herpes zoster and subsequent complications compared to the general population. The recombinant…
  • Abstract Number: 0977 • ACR Convergence 2023

    Prevalence of Arthritis in the United States: National Estimates from a Population-based Study

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Arthritis is the number 1 cause of disability among U.S. adults and reported to cost > $300 billion in direct and indirect costs in…
  • Abstract Number: 1166 • ACR Convergence 2023

    Patients with COVID-19 and Polymyositis Inpatient Outcomes and Hospital Cost: Nationwide Inpatient Sample 2020

    Emily He1 and Vaneet Sandhu2, 1Loma Linda University Health, Loma Linda, CA, 2Loma Linda University, Loma Linda, CA

    Background/Purpose: During the COVID-19 pandemic, there were growing concerns regarding the impact of SARS-CoV-2 on not only patients with rheumatic diseases but also the national…
  • Abstract Number: 1821 • ACR Convergence 2023

    The “Weekend Effect” and Rheumatological Association in Patients with Diffuse Alveolar Haemorrhage

    Shobhit Piplani1, Shreya Gulati2, Vladimir Jelic1, Asad Ahmed3, Sung Mi Yoon1, Donclair Brown1, Miroslav Radulovic1 and Beverly Johnson4, 1Jacobi Medical Center/North Central Bronx, Albert Einstein College of Medicine, NYC Health and Hospitals, Bronx, NY, 2Jawahar lal Nehru Medical College, New York, NY, 3SUNY Downstate, Brooklyn, NY, 4Albert Einstein College of Medicine, Jacobi/NCB, New York, NY

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication commonly associated with autoimmune disorders. Limited treatment options are available for DAH, and time to…
  • Abstract Number: 1918 • ACR Convergence 2023

    Nationwide Analysis of Predictors of Sarcoid Inpatient Mortality

    Michael Manansala1, Faria Sami2, Shilpa Arora3 and Augustine Manadan1, 1Rush University Medical Center, Chicago, IL, 2John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 3Cook County Hospital, Chicago, IL

    Background/Purpose: Sarcoidosis is multisystem autoimmune disease characterized by noncaseating granulomas which can result in significant morbidity and mortality. This study aims to identify variables associated…
  • Abstract Number: 1947 • ACR Convergence 2023

    National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England

    Jennifer Hannah1, Fiona Pearce2, Myron Odingo2, Megan Rutter2, Jeanette Aston3, Jennifer Lai3, Matthew Grainge2, Sean Mcphail3, Peter Lanyon2, Mary Bythell3, James Galloway4 and Patrick Gordon5, 1King's College London, London, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3National Disease Registration Service, Leeds, United Kingdom, 4King's College London, London, United Kingdom, 5NHS, London, United Kingdom

    Background/Purpose: Ethnicity, sex, age & socioeconomic deprivation can all lead to health inequity. Impact of these factors in epidemiology of Idiopathic Inflammatory Myopathies (IIM) has…
  • Abstract Number: 0462 • ACR Convergence 2022

    Increasing Incidence of Large Artery Manifestations in Patients with Giant Cell Arteritis, a Population-based Cohort over 70 Years

    Mohanad Elfishawi1, Mahmut Kaymakci2, Sara Achenbach3, Cynthia Crowson4, Tanaz Kermani5, Cornelia Weyand4, Matthew J. Koster1 and Kenneth J. Warrington1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, 3Mayo Clinic, Rochester, MN, Rochester, MN, 4Mayo Clinic, Eyota, MN, 5University of California Los Angeles, Los Angeles, CA

    Background/Purpose: Screening for large artery manifestations has been adopted by clinicians managing patients with Giant Cell Arteritis (GCA). The contemporary effect of the increased use…
  • Abstract Number: 2232 • ACR Convergence 2022

    Clinical Features and Long-term Outcomes of Patients with Systemic Polyarteritis Nodosa Diagnosed Since 2005: Data from 196 Patients

    Julien ROHMER1, ludovic trefond2, Yann Nguyen3, Christian Agard4, Jean Sebastien ALLAIN5, Alice Berezne6, Pierre Charles7, Pascal Cohen8, guillaume gondran9, Matthieu GROH10, Tessa HUSCENOT11, carole lacout12, Estibaliz Lazaro13, Jonathan London14, Francois Maurier15, Arsene Mekinian16, Isabelle Nubourgh17, Rafik MESBAH18, Xavier Puéchal8, Laurent Perard19, Mathieu Puyade20, Gregory Pugnet21, Viviane Queyrel22, Diane Rouzaud23, Arthur Roux24, Cecile-Audrey DUREL19, Loïc Guillevin8 and Benjamin Terrier8, 1APHP, Suresnes, France, 2Chu clermont ferrand, Clermont-Ferrand, France, 3AP-HP.Centre Universit Paris Cit Hôpital Cochin, Montmorency, France, 4Internal medicine, Nantes University Hospital, Nantes, France, 5CHU rennes, Rennes, 6CH Annecy, Annecy, France, 7Institut Mutualiste Montsouris, Service de Médecine Interne, Paris, France, 8National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 9CHU limoges, Limoges, France, 10Foch Hospital, Suresnes, France, 11APHP, Boulogne, France, 12CHU Angers, Angers, France, 13Bordeaux Hospital University, Bordeaux, France, 14Hôpital Croix-Saint-Simon, Paris, France, 15Hôpitaux privés de Metz, Metz, France, 16AP-HP, Hopital Saint Antoine, Paris, France, 17Ch St Pierre, Brussels, Belgium, 18Boulogne Ch, Boulogne, France, 19CHU Lyon, Lyon, France, 20Centre Hospitalier Universitaire de Poitiers, Poitiers, France, 21CHU Toulouse Purpan Service de Medecine Interne, Toulouse, France, 22CHU NIce, Nice, France, 23Bichat, Paris, France, 24MGEN, Paris, France

    Background/Purpose: The etiological landscape of systemic polyarteritis nodosa (PAN) has substantially changed since the onset of hepatitis B virus (HBV) vaccination and the discovery of…
  • Abstract Number: 0564 • ACR Convergence 2022

    Identifying Shared Genetic Architecture Between RA and Other Conditions: A Phenome-Wide Association Study

    Harrison Zhang1, Gregory McDermott2, Thany Seyok2, Sicong Huang2, Kumar Dahal2, Sehi L'Yi1, Clara Lea-Bonzel1, Jacklyn Stratton2, Dana Weisenfeld2, Tianrun Cai2, Paul Monach3, Jing Cui2, Chuan Hong4, Tianxi Cai5 and Katherine Liao2, 1Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3VA Boston Healthcare System, Boston, MA, 4Duke University, Durham, NC, 5Harvard TH Chan School of Public Health, Boston, MA

    Background/Purpose: RA shares individual risk alleles with other autoimmune conditions such as type 1 diabetes and celiac disease. However, there are limited studies examining the…
  • Abstract Number: PP12 • ACR Convergence 2022

    We Became Advocates, Educators, and a Support System for Hispanic/Latino Patients with Rheumatoid Arthritis and Their Caregivers Through Involvement in a Virtual Patient Advisory Board

    Zucy Almonacid1, Wigna Cruz2, Francisca Garcia3, Teresa Hernandez4, Velia Martinez5, Patricia Mattos3, Mario Mutis6 and Denise Serrano7, 1Hicsville, NY, 2Juan Diaz, PR, 3Lake Worth, FL, 4Greenacres, FL, 5Guaynabo, PR, 6Fort Pierce, FL, 7Toa Alto, PR

    Background/Purpose: Each of us has been diagnosed with rheumatoid arthritis (RA), from as recently as one year ago to as long as 20 years ago.…
  • Abstract Number: 0768 • ACR Convergence 2022

    Reevaluating Clinical Outcomes of Patients on Combination Biologics

    Ryan Mathew1, Alexa Meara2, ChienWei Chiang3, Komal Paradakar3, Ambra Burrell3 and Gabriel Kirsch3, 1The Ohio State University Medical Center, Skokie, IL, 2The Ohio State University Wexner Medical Center, Columbus, OH, 3The Ohio State University Medical Center, Columbus, OH

    Background/Purpose: Biologic treatments such as monoclonal antibodies have become first line treatment for many autoimmune diseases and now monoclonal antibodies are being used to treated…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology